It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The in vivo function of cell-derived extracellular vesicles (EVs) is challenging to establish since cell-specific EVs are difficult to isolate and differentiate. We, therefore, created an EV reporter using truncated CD9 to display enhanced green fluorescent protein (EGFP) on the EV surface. CD9truc-EGFP expression in cells did not affect EV size and concentration but enabled co-precipitation of EV markers TSG101 and ALIX from the cell-conditioned medium by anti-GFP immunoprecipitation. We then created a transgenic mouse where CD9truc-EGFP was inserted in the inverse orientation and double-floxed, ensuring irreversible Cre recombinase-dependent EV reporter expression. We crossed the EV reporter mice with mice expressing Cre ubiquitously (CMV-Cre), in cardiomyocytes (αMHC-MerCreMer) and renal tubular epithelial cells (Pax8-Cre), respectively. The CD9truc-EGFP positive mice showed Cre-dependent EGFP expression, and plasma CD9truc-EGFP EVs were immunoprecipitated only from CD9truc-EGFP positive CD9truc-EGFPxCMV-Cre and CD9truc-EGFPxαMHC-Cre mice, but not in CD9truc-EGFPxPax8-Cre and CD9truc-EGFP negative mice. In urine samples, CD9truc-EGFP EVs were detected by immunoprecipitation only in CD9truc-EGFP positive CD9truc-EGFPxCMV-Cre and CD9truc-EGFPxPax8-Cre mice, but not CD9truc-EGFPxαMHC-Cre and CD9truc-EGFP negative mice. In conclusion, our EV reporter mouse model enables Cre-dependent EV labeling, providing a new approach to studying cell-specific EVs in vivo and gaining a unique insight into their physiological and pathophysiological function.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University of Southern Denmark, Department of Molecular Medicine, Cardiovascular and Renal Research, Odense C, Denmark (GRID:grid.10825.3e) (ISNI:0000 0001 0728 0170)
2 Aarhus University, Department of Molecular Biology and Genetics, Aarhus C, Denmark (GRID:grid.7048.b) (ISNI:0000 0001 1956 2722)
3 Odense University Hospital, Department of Clinical Genetics, Odense C, Denmark (GRID:grid.7143.1) (ISNI:0000 0004 0512 5013); University of Southern Denmark, Clinical Genome Center, Odense C, Denmark (GRID:grid.10825.3e) (ISNI:0000 0001 0728 0170)
4 University of Southern Denmark, Department of Molecular Medicine, Cardiovascular and Renal Research, Odense C, Denmark (GRID:grid.10825.3e) (ISNI:0000 0001 0728 0170); Odense University Hospital, Department of Nephrology, Odense C, Denmark (GRID:grid.7143.1) (ISNI:0000 0004 0512 5013)
5 Odense University Hospital, DCA-Lab, Department of Clinical Biochemistry and Pharmacology, Odense C, Denmark (GRID:grid.7143.1) (ISNI:0000 0004 0512 5013); University of Southern Denmark, Department of Clinical Research, Odense C, Denmark (GRID:grid.10825.3e) (ISNI:0000 0001 0728 0170)